West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 4.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 312,977 shares of the medical instruments supplier’s stock after acquiring an additional 11,898 shares during the period. Principal Financial Group Inc. owned about 0.42% of West Pharmaceutical Services worth $29,583,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Harfst & Associates Inc. acquired a new stake in shares of West Pharmaceutical Services during the 1st quarter valued at $186,000. CIBC Asset Management Inc acquired a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $223,000. Tyers Asset Management LLC lifted its position in shares of West Pharmaceutical Services by 17.6% during the 1st quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after acquiring an additional 368 shares during the last quarter. Cutler Group LP lifted its position in shares of West Pharmaceutical Services by 482.2% during the 2nd quarter. Cutler Group LP now owns 2,550 shares of the medical instruments supplier’s stock valued at $241,000 after acquiring an additional 2,112 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of West Pharmaceutical Services by 1.6% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after acquiring an additional 40 shares during the last quarter. Institutional investors own 91.25% of the company’s stock.

Shares of West Pharmaceutical Services, Inc. (NYSE:WST) traded up 4.61% during mid-day trading on Friday, reaching $95.91. 761,446 shares of the company’s stock traded hands. The company’s 50 day moving average is $87.41 and its 200-day moving average is $89.29. The firm has a market cap of $7.10 billion, a price-to-earnings ratio of 41.16 and a beta of 1.13. West Pharmaceutical Services, Inc. has a 52 week low of $70.17 and a 52 week high of $99.91.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The company had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406.00 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the firm posted $0.59 earnings per share. Equities analysts expect that West Pharmaceutical Services, Inc. will post $2.68 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be given a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.58%. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Tuesday, October 17th. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 22.22%.

TRADEMARK VIOLATION NOTICE: “West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Principal Financial Group Inc.” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://ledgergazette.com/2017/09/16/west-pharmaceutical-services-inc-wst-shares-bought-by-principal-financial-group-inc.html.

Several analysts have issued reports on the stock. Zacks Investment Research downgraded shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Wednesday, July 19th. Jefferies Group LLC reissued a “hold” rating and set a $90.00 target price on shares of West Pharmaceutical Services in a research note on Thursday, June 8th. Finally, BidaskClub downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Two analysts have rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $98.52.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply